MedPath

Dynamics of HBV markers during nucleotide analogue treatment

Not Applicable
Conditions
HBV carrier
Registration Number
JPRN-UMIN000026038
Lead Sponsor
Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

HBVDNA breakthrough

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The rate of patients who showed low HBsAg and HBcrAg during NA treatment
Secondary Outcome Measures
NameTimeMethod
Predicting factors
© Copyright 2025. All Rights Reserved by MedPath